PPT-Issues Affecting ART Success: Adherence, ARV Toxicity, Drug Interactions

Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents April 2015 AETC NCRC Slide Set 2 July 2016 wwwaidsetcorg About This Presentation These slides were developed using the April 2015 . www.YourDiabetesInfo.org/MedicationAdherence. . Medication Adherence: Resources for Patients. Medication Adherence: Resources for Health Care Teams. Medication Adherence: Scientific Evidence. Criteria For Inclusion. Bernard Vrijens, PhD. Chief Science Officer, MWV Healthcare. Associate Professor of Biostatistics . University of Liège, Belgium. Adherence is key to therapeutic success. 2. Effective. Disease. Management. EXPERIENCE FROM MALAYSIA. BY. SHA’ARI NGADIMAN, . . MD, MPH, EIP, AM. MINISTRY OF HEALTH MALAYSIA. Our Structure. National Strategic Plan on HIV and AIDS. Activities. Impacts of the activities. AIDS Expenditure. Dr. Naila Abrar. LEARNING OBJECTIVES. By the end of this session you should be able . to: . define . drug . toxicity;. know . the types of . toxicity;. comprehend . the reasons that may lead to toxicity of . Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents . April 2015. AETC . NCRC . Slide Set. 2. July 2016. www.aidsetc.org. About This Presentation. These slides were developed using the April 2015 . Simi Padival, MD. November 3, 2016. Objectives. Learn about the importance of assessing adherence to antiretroviral therapy (ART). Learn about the components of assessing for ART adherence. Discuss frequency of monitoring while on ART. Meg . Doherty, MD, PhD, MPH. 19 July 2015. WHO Satellite. Vancouver – IAS 2015. Objectives of Presentation. 2015 ARV Guidelines update - why now?. Overview . of Evidence Base . New . directions in . V. . Habiyambere. , . J. . Perriëns. , B. Dongmo-Nguimfack, . World Health Organization. On behalf of the ARV . Forecasting Technical Working . Group. UNAIDS, CHAI, UNICEF, Global Fund, PEPFAR (SCMS, USAID), and Futures Institute. Dr. Seema Sahay, Ph.D. Division of Social and Behavioral Research. National AIDS Research Institute. Indian Council of Medical Research, Pune (India). Overview. Defining and measuring adherence. Issues around adherence. relevance and options for the future. B. Dongmo Nguimfack. AMDS . TCO Unit/HIV, WHO. . . What is AMDS. The AMDS is a network of technical partner organisations that work to support countries in procurement and supply management of HIV commodities. The secretariat of this network is housed in WHO/HIV Department. Clinical aspects of ADRs in HIV and ARV toxicity monitoring approaches Workshop on management and reporting of adverse drug reactions related to ARVs 26 June 2018, Gaborone, Botswana Presentation Outline 1 City in Addis Ababa A Proposal on the CHBC Project Lisan Atnafe: CHBC Project Officer Anley Haile : MNCH project advisor February 2013 2 Acronyms AIDS Acquired Immunodeficiency Syndrome AMREF Afr Define drug resistance. Identify . factors that influence drug resistance. .. Identify . strategies for minimizing development of drug resistance.. Identify strategies for responding to detection of moderate to high levels of drug resistant HIV.. PLHIV [1]. . Failure . to maintain adherence to ART is causally associated with the progression of HIV to AIDS, increased risk of opportunistic infections, and mortality with lowering of quality of .